NCT04013932

Brief Summary

The goal of this study is to pilot test a culturally tailored Family Psychoeducation model (KUPAA) for adults with psychotic disorders and their relatives that is appropriate for cultural settings inclusive of both traditional and biomedical ideas about mental illness and that incorporates relatives as co-facilitators of the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 10, 2019

Completed
27 days until next milestone

Study Start

First participant enrolled

August 6, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2020

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

February 4, 2022

Completed
Last Updated

February 4, 2022

Status Verified

January 1, 2022

Enrollment Period

1.2 years

First QC Date

July 8, 2019

Results QC Date

November 17, 2021

Last Update Submit

January 7, 2022

Conditions

Keywords

Family PsychoeducationSchizophreniaTanzaniaSevere and Persistent Mental IllnessCulturally tailored

Outcome Measures

Primary Outcomes (3)

  • Proportion of Patient Participants Who Experience Illness Relapse

    Patient relapse measured by hospitalization or non-hospitalized relapse, defined as a new illness episode with recurrence of symptoms after one month of controlled symptoms.

    Relapse is measured from immediate post-intervention to endline (~6-7 months post-intervention)

  • Change From Baseline to Endline in Disability, as Measured by the World Health Organization Disability Assessment Schedule Version 2.0 (WHODAS 2.0)

    Scores are measured from the 36-item WHODAS 2.0, the World Health Organization Disability Assessment Schedule, which measures health and disability. WHODAS 2.0 This self-report assessment measures difficulties performing daily activities over the past 30 days. It consists of 36 Likert-formatted questions across six domains: understanding and communicating, getting around, self-care, getting along with others, life activities, and participation in society. WHO's guidelines for the complex scoring method were used to create the total score, ranging from 0 (no disability) to 100 (full disability). Higher scores indicate worse outcomes.

    Baseline (pre-intervention) and Endline (~6-7 months post-intervention)

  • Change From Baseline to Endline in Quality of Life, as Measured by the World Health Organization Quality of Life- Abbreviated Version (WHOQOL-BREF)

    Raw total scores are measured from the 26-item WHOQOL-BREF (the abbreviated version of the World Health Organization Quality of Life 100 scale). This self-report assessment has 26 questions across four domains; physical health, psychological, social relationships, and environment. Each item is rated on a five-point Likert scale (1-5) ranging from 1 (not at all, very dissatisfied, very poor) to 5 (an extreme amount, very satisfied, very good); three items needed reverse scoring. The range is 26 (min) to 130 (max) for the total raw score. Higher scores indicate a better outcome.

    Baseline (pre-intervention) and Endline (~6-7 months post-intervention)

Study Arms (2)

KUPAA Intervention + Standard of Care

EXPERIMENTAL

Patients will be assigned to a KUPAA group composed of approximately 6 patients (joined by their 6 matched caregivers). Patients will first participate in 1-2 joining sessions with a provider, followed by a 1-day group educational workshop. Participants will then attend weekly family psychoeducation group sessions (\~1.5-2 hours) for 12 weeks.

Behavioral: KUPAA Intervention Group (Culturally Tailored Family Psychoeducation)

Control - Standard of Care

NO INTERVENTION

Patients will receive the standard of care.

Interventions

KUPAA is composed of 3 key components: 1-2 Joining sessions \[\~30 to 45 minutes each\] give the facilitator and participants a chance to get to know each other before KUPAA groups begin and allows time for questions. Educational Workshop is an interactive, one day workshop offering information about biological, psychological and social aspects of mental illness; the nature, effects and side effects of psychiatric treatments; what families can do to help recovery and prevent relapse; and guidelines for managing mental illnesses. 12 Family psychoeducation group sessions \[\~1.5 hours each session\] occur weekly in multi-family groups. These sessions follow an empirically tested format and focus on solving problems that interfere with treatment, illness, and symptoms management and that support coping skills and personal care. Case management may also be provided.

Also known as: FPE, Family psychoeducation
KUPAA Intervention + Standard of Care

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Attending outpatient psychiatric services at Muhimbili National Hospital (MNH) or Mbeya Zonal Referral Hospital (MZRH).
  • ICD-10 Diagnosis of a non-organic psychotic disorder:
  • F20 Schizophrenia
  • F21 Schizotypal disorder
  • F22 Delusional disorders
  • F25 Schizoaffective disorders
  • Age 18-50 at the time of informed consent
  • Hospitalization or relapse (confirmed by attending psychiatrist or medical officer) within the past 12 months.

You may not qualify if:

  • F23 Brief psychotic disorder
  • F28 Other psychotic disorder not due to a substance or known physiological condition
  • F29 Unspecified psychosis not due to a substance or known physiological condition
  • Epileptic psychoses
  • Bipolar disorder and mania
  • Co-morbid developmental disorder, dementia, or other severe cognitive deficit that renders the individual unable to provided informed consent.
  • Age 18 or older at time of consenting process
  • Patient agrees that this person can be their paired partner for KUPAA if the pair is randomized to the intervention group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Muhimbili University of Health and Allied Sciences (MUHAS)

Dar es Salaam, Tanzania

Location

Mbeya Zonal Referral Hospital

Mbeya, Tanzania

Location

Related Publications (2)

  • Egger JR, Kaaya S, Swai P, Lawala P, Ndelwa L, Temu J, Bukuku ES, Lukens E, Susser E, Dixon L, Minja A, Clari R, Martinez A, Headley J, Baumgartner JN. Functioning and quality of life among treatment-engaged adults with psychotic disorders in urban Tanzania: Baseline results from the KUPAA clinical trial. PLoS One. 2024 Jun 18;19(6):e0304367. doi: 10.1371/journal.pone.0304367. eCollection 2024.

  • Martinez A, Baumgartner JN, Kaaya S, Swai P, Lawala PS, Thedai B, Minja A, Headley J, Egger JR. Hopefulness among individuals living with schizophrenia and their caregivers in Tanzania: an actor-partner interdependence model. BMC Psychiatry. 2023 Jul 13;23(1):508. doi: 10.1186/s12888-023-04990-8.

MeSH Terms

Conditions

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersSchizophrenia

Results Point of Contact

Title
Joy Noel Baumgartner
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Joy Noel Baumgartner, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Only the main biostatistician will be masked in the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2019

First Posted

July 10, 2019

Study Start

August 6, 2019

Primary Completion

October 27, 2020

Study Completion

October 27, 2020

Last Updated

February 4, 2022

Results First Posted

February 4, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will share

Adhering to NIMH requirements on sharing data through NIMH Data Archive

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
By November, 2020
Access Criteria
NIMH Data Archive
More information

Locations